Koa Wealth Management LLC grew its holdings in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 37.1% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,658 shares of the financial services provider’s stock after buying an additional 2,615 shares during the quarter. CME Group makes up 1.6% of Koa Wealth Management LLC’s portfolio, making the stock its 20th largest position. Koa Wealth Management LLC’s holdings in CME Group were worth $2,131,000 as of its most recent SEC filing.
A number of other large investors also recently modified their holdings of CME. Y.D. More Investments Ltd acquired a new position in CME Group during the second quarter worth $36,000. McClarren Financial Advisors Inc. grew its position in shares of CME Group by 66.1% in the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after acquiring an additional 78 shares during the period. Asset Dedication LLC increased its stake in shares of CME Group by 515.2% during the 2nd quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock worth $40,000 after purchasing an additional 170 shares during the last quarter. Thurston Springer Miller Herd & Titak Inc. raised its holdings in shares of CME Group by 62.2% in the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock valued at $43,000 after purchasing an additional 74 shares during the period. Finally, Bank & Trust Co acquired a new stake in CME Group in the 2nd quarter valued at about $76,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling at CME Group
In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. This trade represents a 12.01 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Timothy Francis Mccourt sold 1,374 shares of the firm’s stock in a transaction that occurred on Monday, October 28th. The shares were sold at an average price of $227.12, for a total transaction of $312,062.88. Following the completion of the transaction, the insider now owns 7,275 shares of the company’s stock, valued at approximately $1,652,298. This trade represents a 15.89 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 15,621 shares of company stock worth $3,441,063 over the last quarter. Corporate insiders own 0.30% of the company’s stock.
CME Group Price Performance
CME Group (NASDAQ:CME – Get Free Report) last issued its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, topping the consensus estimate of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The firm had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter in the previous year, the firm earned $2.25 earnings per share. The business’s quarterly revenue was up 18.4% on a year-over-year basis. On average, sell-side analysts expect that CME Group Inc. will post 10.23 earnings per share for the current fiscal year.
CME Group Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 9th will be paid a $1.15 dividend. This represents a $4.60 annualized dividend and a yield of 2.04%. The ex-dividend date is Monday, December 9th. CME Group’s payout ratio is 48.37%.
Analysts Set New Price Targets
A number of analysts have recently issued reports on the company. Bank of America raised their price objective on CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a research report on Thursday, October 3rd. Morgan Stanley raised their price target on CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a report on Thursday, October 17th. Redburn Atlantic downgraded shares of CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price objective on the stock. in a report on Tuesday, October 8th. The Goldman Sachs Group boosted their price target on CME Group from $195.00 to $198.00 and gave the company a “sell” rating in a research note on Thursday, October 3rd. Finally, JPMorgan Chase & Co. increased their target price on shares of CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a research report on Thursday, July 25th. Four analysts have rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat.com, CME Group has a consensus rating of “Hold” and an average price target of $224.47.
Check Out Our Latest Stock Report on CME
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Further Reading
- Five stocks we like better than CME Group
- Technology Stocks Explained: Here’s What to Know About Tech
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- What Does Downgrade Mean in Investing?
- Time to Load Up on Home Builders?
- How to Invest in the FAANG Stocks
- Flutter Entertainment Can Be a Blue-Chip Sports Betting Stock
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.